https://www.cancernetwork.com/view/anastrozole-combo-yields-high-clinical-benefit-in-hr-her2-breast-cancer
0
0
12/23/23 at 5:08pm
Organization
Cancernetwork.com
45 words
0
Comments
A future phase 2 trial may compare anastrozole plus a CDK4/6 inhibitor and trastuzumab or pertuzumab with chemotherapy plus trastuzumab and pertuzumab in hormone receptor–positive, HER2-positive metastatic breast cancer.
You are the first to view
Create an account
or login to join the discussion